Biosensors International Pte Ltd（BSI）was founded in 1990, it has experienced more than 20 years of research and development, production, marketing and sales of intensive care medical products. Over the years, our company has been investing in R&D and technology to provide patients with safe and healthy products. By maintaining and operating a consistently applicable quality management system, our products could meet customers’ requirements effectively and also meet the requirements of medical device regulations in the markets we are serving.

From 1991 to 2010, our company continued to develop Thermodilution Catheter, the first generation blood pressure transducer BIOTRANS, Central Venous Catheter, the second generation pressure monitoring systems and kits BIOTRANS II, Embolectomy Catheter, Bipolar Pacing Catheter, new disposable blood pressure transducer, CVC Compound Packet, Non-latex Thermodilution Catheter, new blood pressure transducer Catrans etc., with mature technology and excellent quality, our products have achieved first-class international standards and obtained CE and FDA etc.registration certificates from more than 50 countries and regions around the world. The products are sold to Asia Pacific, Europe, America, Latin America and other countries and regions.

In 2003, Biosensors International Pte Ltd invested and established a wholly-owned subsidiary, JW ICU Medical Limited（JW ICU） in Weihai, China, which expanded China market successfully.

After spin-off from the Biosensors International Group in October 2017, Biosensors International Pte Ltd has kept on expanding the advantages of our CCP critical care business as the global sales center, will gradually build overseas sales subsidiaries, and lay a solid market foundation for new R&D products entering the market.